Skip to main content
. 2020 Mar 6;10:4208. doi: 10.1038/s41598-020-61094-z

Figure 2.

Figure 2

(a) Receiver operating characteristic curves, AUC, Sensitivity and Specificity of Calprotectin, HBP and Procalcitonin in the discrimination between patients with bacterial pneumonia and viral respiratory infections. (b) Receiver operating characteristic curves, AUC, Sensitivity and Specificity of Calprotectin, HBP and Procalcitonin in the discrimination between patients with mycoplasma pneumonia and viral respiratory infections.